Viatris Inc.
VTRS
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; bioā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
46 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$16.51
Price+0.79%
$0.13
1Y
Price
Market Cap
$19.227b
Large
Price/Earnings 3y Avg5y Avg
6.6x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+17.4%
EBITDA Margin-3.2%
Net Profit Margin+8.8%
Free Cash Flow Margin+17.4%
EBITDA Margin-3.2%
Net Profit Margin+8.8%
Free Cash Flow MarginRevenue
$14.737b
+3.1%
1y CAGR-1.5%
3y CAGR-2.4%
5y CAGREarnings
-$410.700m
+88.3%
1y CAGR-541.8%
3y CAGR-430.7%
5y CAGREPS
-$0.36
+88.0%
1y CAGR-512.7%
3y CAGR-408.8%
5y CAGRBook Value
$14.260b
$35.045b
Assets$20.784b
Liabilities$13.626b
DebtDebt to Assets
38.9%
5.2x
Debt to EBITDAFree Cash Flow
$1.873b
-3.3%
1y CAGR-6.8%
3y CAGR-6.9%
5y CAGRNo items found.
Press Releases
Statements and updates from the company